Data / Drug companies / Cintex Services, LLC
Cintex Services, LLC: 33 products in the FDA NDC directory, labeler code 24470
Cintex Services, LLC (labeler code 24470) lists 33 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 30 prescription drugs, 3 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on October 5, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 24470
- Products in commercial distribution
- 33
- Packages
- 41
- Finished drugs by generic name
- 13
- Prescription products
- 30
- Over the counter products
- 3
- Flagged as original packager
- 32 of 32 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- August 15, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 24 | 72.7% |
| Generic drugs (ANDA) | 6 | 18.2% |
| Over the counter monograph drugs | 3 | 9.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 30 | 90.9% |
| Over the counter drugs | 3 | 9.1% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Sulfacetamide sodium, sulfur | 10 | 13 |
| Benzoyl peroxide | 3 | 82 |
| Salicylic acid | 3 | 330 |
| Sodium sulfacetamide, sulfur | 3 | 4 |
| Urea | 2 | 17 |
| Lidocaine hydrochloride, hydrocortisone acetate | 2 | 1 |
| Sulfacetamide sodium | 2 | 13 |
| Chlorzoxazone | 2 | 21 |
| Selenium sulfide | 1 | 28 |
| Ergotamine tartrate and caffeine | 1 | 3 |
| Desonide | 1 | 15 |
| Diclofenac potassium, film coated | 1 | 8 |
| Triamcinolone acetonide | 1 | 77 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 6 | 18.2% |
| Lotion | 5 | 15.2% |
| Emulsion | 4 | 12.1% |
| Cream | 4 | 12.1% |
| Tablet | 4 | 12.1% |
| Gel | 3 | 9.1% |
| Solution | 2 | 6.1% |
| Suspension | 2 | 6.1% |
| Shampoo | 1 | 3% |
| Tablet, film coated | 1 | 3% |
| Ointment | 1 | 3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Uribel Tabs | 24470-967 | Tablet | Other unapproved drugs | October 5, 2026 |
| Sodium sulfacetamide, sulfur | 24470-953 | Liquid | Other unapproved drugs | April 23, 2026 |
| Urea | 24470-962 | Lotion | Other unapproved drugs | October 20, 2025 |
| Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser | 24470-955 | Liquid | Other unapproved drugs | October 20, 2025 |
| Sodium sulfacetamide, sulfur | 24470-951 | Suspension | Other unapproved drugs | October 20, 2025 |
| Sodium sulfacetamide, sulfur | 24470-950 | Liquid | Other unapproved drugs | October 20, 2025 |
| Salicylic acid | 24470-949 | Liquid | Other unapproved drugs | October 20, 2025 |
| Salicylic Acid | 24470-948 | Solution | Other unapproved drugs | October 20, 2025 |
| Xalix | 24470-947 | Solution | Other unapproved drugs | October 20, 2025 |
| Plexion | 24470-941 | Liquid | Other unapproved drugs | October 20, 2025 |
| Selenium sulfide | 24470-960 | Shampoo | Other unapproved drugs | July 10, 2025 |
| Plexion | 24470-942 | Cream | Other unapproved drugs | July 10, 2025 |
| Sulfacetamide sodium, sulfur | 24470-957 | Lotion | Other unapproved drugs | February 26, 2025 |
| Sulfacetamide sodium, sulfur | 24470-956 | Cream | Other unapproved drugs | February 26, 2025 |
| Plexion | 24470-944 | Lotion | Other unapproved drugs | February 26, 2025 |
| Lidocaine hydrochloride, hydrocortisone acetate | 24470-965 | Cream | Other unapproved drugs | September 11, 2024 |
| Lidocaine hydrochloride, hydrocortisone acetate | 24470-964 | Gel | Other unapproved drugs | September 11, 2024 |
| Sulfacetamide sodium | 24470-937 | Liquid | Other unapproved drugs | September 4, 2024 |
| Chlorzoxazone | 24470-940 | Tablet | Generic drugs (ANDA) | March 21, 2024 |
| Urea | 24470-939 | Cream | Other unapproved drugs | January 23, 2024 |
| Sulfacetamide sodium | 24470-935 | Gel | Other unapproved drugs | January 23, 2024 |
| Sulfacetamide sodium, sulfur | 24470-934 | Lotion | Other unapproved drugs | January 23, 2024 |
| Sulfacetamide sodium, sulfur | 24470-933 | Suspension | Other unapproved drugs | January 23, 2024 |
| Sulfacetamide sodium, sulfur | 24470-932 | Lotion | Other unapproved drugs | January 23, 2024 |
| Sulfacetamide sodium, sulfur | 24470-925 | Emulsion | Other unapproved drugs | January 23, 2024 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.